ERBB2/HER2-low breast cancer is considered a subtype of hormone receptor-positive, HER2 positive but not amplified breast cancer and is being treated in a similar way to the HER2-enriched subtype (Marchiò et al., 2021). The gene discussed is NR4A1; the disease is breast carcinoma.